Creso Pharma Limited (ASX: CPH) has finalised a number of steps to launch its newly developed, innovative cannaDOL gel products into the sport, health and wellness markets in Switzerland.
The attack on the Swiss market will be made through all established commercial channels and the recently developed Creso Pharma cannaDOL ecommerce website.
The launch follows considerable research, development and technical evaluation of the cannaDOL product portfolio. Following this, the Company has developed two new products, including cannaDOL Boost, which is to be used before sport and recreational activity and cannaDOL Recovery, which aids in recovery from sport and other physical activities.
Both complementary products use the newly developed hemp CBD tea-based technology. cannaDOL Boost ingredients are based on a unique formula of caffeine, taurine, vitamins and minerals providing an energy boost, whereas cannaDOL Recovery is based on a unique formula containing lemon balm and curcumin in addition to vitamins and minerals.
Creso Pharma says it will now launch the new products through its established distribution footprint and commercial partners to target the lucrative sporting, recreation and health and fitness markets.
The company is also progressing product introduction across a number of European markets including Poland and Portugal.
Commercial Director, Dr Gian Trepp, said Creso Pharma has access to a number of major wholesalers in Switzerland with the company’s reach extending to over 2,100 points of sale including pharmacies, pharmacy networks, drugstores and over 400 sport and fitness centres. Amongst these is the large retail shop Manor, which is a major department store chain with stores across Switzerland. Creso Pharma is currently supplying all major wholesalers in the country such as Galexis, Amedis and Voigt.
The recent development of our ecommerce channel and new products formulations is a very pleasing development and we are proud to substantially strengthen our sport products portfolio with cannaDOL Boost and Recovery,” Dr Trepp said.
“Recent initiatives will assist the xompany to expand its leading presence in the Swiss and European sports markets, which provide another high yield and low risk opportunity for the company. Discussions with additional partners and specialty retailers are ongoing and we anticipate that further growth can be achieved across Europe and more broadly.”
